BR112014001066A2 - toxinas botulínicas para uso em um método para tratamento de depósitos adiposos - Google Patents
toxinas botulínicas para uso em um método para tratamento de depósitos adipososInfo
- Publication number
- BR112014001066A2 BR112014001066A2 BR112014001066A BR112014001066A BR112014001066A2 BR 112014001066 A2 BR112014001066 A2 BR 112014001066A2 BR 112014001066 A BR112014001066 A BR 112014001066A BR 112014001066 A BR112014001066 A BR 112014001066A BR 112014001066 A2 BR112014001066 A2 BR 112014001066A2
- Authority
- BR
- Brazil
- Prior art keywords
- botulinum toxins
- treating adipose
- adipose deposits
- deposits
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
- A61K38/4893—Botulinum neurotoxin (3.4.24.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/91—Injection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Birds (AREA)
- Child & Adolescent Psychology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
resumo patente de invenção: "toxinas botulínicas para uso em um método para tratamento de depósitos adiposos". modalidades da invenção incluem métodos e composições para tratamento de depósitos adiposos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161509700P | 2011-07-20 | 2011-07-20 | |
PCT/US2012/047405 WO2013013042A1 (en) | 2011-07-20 | 2012-07-19 | Botulinum toxins for use in a method for treatment of adipose deposits |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112014001066A2 true BR112014001066A2 (pt) | 2017-02-21 |
Family
ID=46601917
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112014001066A BR112014001066A2 (pt) | 2011-07-20 | 2012-07-19 | toxinas botulínicas para uso em um método para tratamento de depósitos adiposos |
Country Status (12)
Country | Link |
---|---|
US (1) | US20140127188A1 (pt) |
EP (1) | EP2734224A1 (pt) |
JP (1) | JP2014520892A (pt) |
KR (1) | KR20140082956A (pt) |
CN (1) | CN103702681A (pt) |
AU (1) | AU2012283968B2 (pt) |
BR (1) | BR112014001066A2 (pt) |
CA (1) | CA2841955A1 (pt) |
IN (1) | IN2014DN00254A (pt) |
MX (1) | MX2014000612A (pt) |
RU (1) | RU2014103543A (pt) |
WO (1) | WO2013013042A1 (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9486408B2 (en) * | 2005-12-01 | 2016-11-08 | University Of Massachusetts Lowell | Botulinum nanoemulsions |
US9655926B1 (en) | 2013-08-23 | 2017-05-23 | Amiya Prasad | Treatment for hair thinning and hair loss |
WO2016021985A1 (ko) * | 2014-08-07 | 2016-02-11 | 김상덕 | 보툴리눔 독소와 공기의 혼합물을 포함하는 안면 윤곽 교정용 조성물 및 이를 이용한 안면 윤곽 교정 방법 |
US11040989B2 (en) | 2015-12-18 | 2021-06-22 | Jiangsu Nata Opto-Electronic Materials Co., Ltd. | Tris(disilanyl)amine |
JP2019535829A (ja) | 2016-11-21 | 2019-12-12 | エイリオン セラピューティクス, インコーポレイテッド | 大型薬剤の経皮送達 |
JP2020520917A (ja) * | 2017-05-18 | 2020-07-16 | ルバンス セラピュティックス インク.Revance Therapeutics,Inc. | 頸部ジストニアの治療方法 |
US20190030118A1 (en) * | 2017-07-27 | 2019-01-31 | Ipsen Biopharm Limited | Treatment of lower limb spasticity |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9120306D0 (en) | 1991-09-24 | 1991-11-06 | Graham Herbert K | Method and compositions for the treatment of cerebral palsy |
US5437291A (en) | 1993-08-26 | 1995-08-01 | Univ Johns Hopkins | Method for treating gastrointestinal muscle disorders and other smooth muscle dysfunction |
US6974578B1 (en) | 1993-12-28 | 2005-12-13 | Allergan, Inc. | Method for treating secretions and glands using botulinum toxin |
US5766605A (en) | 1994-04-15 | 1998-06-16 | Mount Sinai School Of Medicine Of The City University Of New York | Treatment of autonomic nerve dysfunction with botulinum toxin |
DE69526340T2 (de) | 1994-05-09 | 2002-11-14 | William J Binder | Botulinumtoxin ZUR REDUKTION VON Migraine -KOPFSCHMERZEN |
US5670484A (en) | 1994-05-09 | 1997-09-23 | Binder; William J. | Method for treatment of skin lesions associated with cutaneous cell-proliferative disorders |
GB9508204D0 (en) | 1995-04-21 | 1995-06-07 | Speywood Lab Ltd | A novel agent able to modify peripheral afferent function |
CN1321683C (zh) | 1997-07-15 | 2007-06-20 | 科罗拉多大学董事会 | 神经毒素疗法在泌尿系及相关疾病治疗中的应用 |
US6063768A (en) | 1997-09-04 | 2000-05-16 | First; Eric R. | Application of botulinum toxin to the management of neurogenic inflammatory disorders |
US6113915A (en) | 1999-10-12 | 2000-09-05 | Allergan Sales, Inc. | Methods for treating pain |
US6265379B1 (en) | 1999-10-13 | 2001-07-24 | Allergan Sales, Inc. | Method for treating otic disorders |
US6139845A (en) | 1999-12-07 | 2000-10-31 | Allergan Sales, Inc. | Method for treating cancer with a neurotoxin |
US6143306A (en) | 2000-01-11 | 2000-11-07 | Allergan Sales, Inc. | Methods for treating pancreatic disorders |
US6358513B1 (en) | 2000-02-15 | 2002-03-19 | Allergan Sales, Inc. | Method for treating Hashimoto's thyroiditis |
US6319506B1 (en) * | 2000-02-22 | 2001-11-20 | Allergan, Sales, Inc. | Method for treating hypercalcemia |
US6464986B1 (en) | 2000-04-14 | 2002-10-15 | Allegan Sales, Inc. | Method for treating pain by peripheral administration of a neurotoxin |
US6299893B1 (en) | 2000-04-17 | 2001-10-09 | Marvin Schwartz | Method to reduce hair loss and stimulate hair regrowth |
US6306423B1 (en) | 2000-06-02 | 2001-10-23 | Allergan Sales, Inc. | Neurotoxin implant |
US6306403B1 (en) | 2000-06-14 | 2001-10-23 | Allergan Sales, Inc. | Method for treating parkinson's disease with a botulinum toxin |
US6423319B1 (en) | 2000-10-04 | 2002-07-23 | Allergan Sales, Inc. | Methods for treating muscle injuries |
CA2496005C (en) * | 2002-08-19 | 2013-07-23 | Ira Sanders | Use of botulinum toxin for the treatment of fine wrinkles and pore size |
ES2691498T3 (es) * | 2004-03-03 | 2018-11-27 | Revance Therapeutics, Inc. | Aplicación tópica y liberación transdérmica de toxinas botulínicas |
US7179474B2 (en) * | 2004-09-03 | 2007-02-20 | Allergan, Inc. | Methods for treating a buttock deformity |
CA2518650A1 (en) * | 2004-09-10 | 2006-03-10 | Dimitrios Dimitrakoudis | Clostridium botulinum toxin formulation and method for reducing weight |
US20080220021A1 (en) * | 2005-02-14 | 2008-09-11 | Pankaj Modi | Topical Botulinum Toxin Compositions for the Treatment of Hyperhidrosis |
US7727537B2 (en) * | 2005-02-14 | 2010-06-01 | Dpm Therapeutics Corp. | Stabilized compositions for topical administration and methods of making same |
HUE054852T2 (hu) * | 2005-12-01 | 2021-10-28 | Univ Massachusetts Lowell | Botulinum nanoemulziók |
JP2010536892A (ja) * | 2007-08-31 | 2010-12-02 | ディーエスエム アイピー アセッツ ビー.ブイ. | 化粧的及び/又は皮膚科学的使用のための4−アミジノベンジルアミン |
US20090297632A1 (en) * | 2008-06-02 | 2009-12-03 | Waugh Jacob M | Device, Methods and Compositions to Alter Light Interplay with Skin |
CN105147608B (zh) * | 2008-06-26 | 2019-12-10 | 安特里奥公司 | 真皮递送 |
JP6006940B2 (ja) * | 2009-03-02 | 2016-10-12 | ヘクセル,ドリス | 医学的美容脂肪萎縮方法 |
-
2012
- 2012-07-19 BR BR112014001066A patent/BR112014001066A2/pt not_active Application Discontinuation
- 2012-07-19 US US14/233,667 patent/US20140127188A1/en not_active Abandoned
- 2012-07-19 MX MX2014000612A patent/MX2014000612A/es unknown
- 2012-07-19 RU RU2014103543/15A patent/RU2014103543A/ru not_active Application Discontinuation
- 2012-07-19 KR KR1020147004213A patent/KR20140082956A/ko not_active Application Discontinuation
- 2012-07-19 EP EP12741438.1A patent/EP2734224A1/en not_active Withdrawn
- 2012-07-19 JP JP2014521786A patent/JP2014520892A/ja active Pending
- 2012-07-19 WO PCT/US2012/047405 patent/WO2013013042A1/en active Application Filing
- 2012-07-19 AU AU2012283968A patent/AU2012283968B2/en not_active Ceased
- 2012-07-19 IN IN254DEN2014 patent/IN2014DN00254A/en unknown
- 2012-07-19 CA CA2841955A patent/CA2841955A1/en not_active Abandoned
- 2012-07-19 CN CN201280035860.8A patent/CN103702681A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
CN103702681A (zh) | 2014-04-02 |
AU2012283968B2 (en) | 2016-04-14 |
JP2014520892A (ja) | 2014-08-25 |
IN2014DN00254A (pt) | 2015-06-05 |
RU2014103543A (ru) | 2015-08-27 |
MX2014000612A (es) | 2014-02-27 |
US20140127188A1 (en) | 2014-05-08 |
CA2841955A1 (en) | 2013-01-24 |
WO2013013042A1 (en) | 2013-01-24 |
AU2012283968A1 (en) | 2014-02-06 |
EP2734224A1 (en) | 2014-05-28 |
KR20140082956A (ko) | 2014-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112014001066A2 (pt) | toxinas botulínicas para uso em um método para tratamento de depósitos adiposos | |
BR112014014234A2 (pt) | composição não colorante para tratar as fibras queratínicas e método para tratar as fibras queratínicas | |
BR112014028017A2 (pt) | composto, composição farmacêutica, método para tratar um distúrbio, método para reduzir a quantidade il-17 em um indivíduo e método para inibir a atividade de ror | |
AR089993A1 (es) | Macrociclos peptidomimeticos | |
BR112014010162A2 (pt) | uso de composição, método para melhorar o reconhecimento e/ou tratar ou prevenir função de reconhecimento prejudicada em um indivíduo, e composição | |
CL2013003638A1 (es) | Compuestos inhibidores de metaloenzimas; composición que comprende dichos compuestos; uso de la composición para tratar o prevenir una enfermedad asociada a metaloenzimas en plantas; uso para inhibir metaloenzimas en microorganismos y tratar un trastorno fúngico en plantas. | |
BR112012029897A2 (pt) | método para reduzir a quantidade de uma serina protease ou um zimogênio de serina protease em uma composição, método para preparar uma composição, composição de proteína derivada de plasma, e, método para tratamento de uma doença | |
UY34675A (es) | ?proceso y aparato para tratar superficies de metal?. | |
CL2013001947A1 (es) | Composicion farmaceutica que comprende pioglitazona; uso de pioglitazona para tratar alzheimer; composicion que comprende pioglitazona. | |
BR112013025006A2 (pt) | composições e métodos para inibição de expressão do gene tmprss6 | |
BR112013029773A2 (pt) | canabinoides para uso no tratamento de dor neuropática | |
SG10201804472YA (en) | SERPINA1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF | |
BR112013030832A2 (pt) | processo para tratar as fibras queratínicas e uso de uma composição | |
BR112014026740A2 (pt) | anticorpo, composição, métodos para tratar um mamífero e para fornecer um anticorpo com adcc realçada, e, uso de um anticorpo | |
BR112015005369A2 (pt) | inibidores de usp30 e métodos para sua utilização | |
BR112015030356A2 (pt) | métodos de tratamento de uma taupatia | |
RS53893B1 (en) | USE OF BIOTIN FOR MULTIPLE SCLEROSIS TREATMENT | |
MX349886B (es) | Moleculas de union anti-pseudomonas lectina pisum satinum (psl) y usos de las mismas. | |
MX354270B (es) | Uso de un anticuerpo antiesclerostina en el tratamiento de la pérdida ósea alveolar. . | |
BR112014003875A2 (pt) | kit e método de limpeza de cabelo | |
BR112014000634A2 (pt) | métodos para tratamento de incontinência associada com atividade sexual | |
BR112014026795A2 (pt) | composição cosmética , processo cosmético para tratar a matéria queratínica e uso de uma composição cosmética. | |
BR112014000216A2 (pt) | processo cosmético para tratar as matérias queratínicas e kit | |
BR112014011481A2 (pt) | hidrolisado de colágeno e seu uso | |
BR112014030279A2 (pt) | métodos para tratamento de neutropenia usando agonistas retinóide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B11E | Dismissal acc. art. 34 of ipl - requirements for examination incomplete | ||
B11T | Dismissal of application maintained [chapter 11.20 patent gazette] |